Latest News and Press Releases
Want to stay updated on the latest news?
-
Plenary Presentation Highlights How Aligning Inflammatory Biomarker Enrichment with Mechanism of Action Offers a Blueprint for Success in Alzheimer’s Drug Development Boca Raton, FL, March 19, 2026 ...
-
SALT LAKE CITY, March 17, 2026 (GLOBE NEWSWIRE) -- Breeze Airways, the premium leisure carrier providing affordable, direct flights from underserved markets, today announced new nonstop...
-
SAN DIEGO, March 03, 2026 (GLOBE NEWSWIRE) -- At a pivotal moment in global geopolitics — marked by cyberattacks, AI-driven defense systems, space militarization, and escalating international...
-
Amplify ETFs announces the Amplify CWP International Enhanced Dividend Income ETF (IDVO) has exceeded $1 billion in assets under management.
-
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor ACI-19764 is an orally available highly brain-penetrant small molecule NLRP3 inhibitorNLRP3 inhibitors are a major new class of...
-
Wrap Conducts Instructor Retraining and Program Expansion with Malta National Police Force
-
NEW YORK, NY; NEW HAVEN, CT; PRINCETON, NJ, and TAIPEI, TAIWAN, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage...
-
Breeze Expands Its Nice, Nonstop Service to New Destinations, Including Nassau, Bahamas, This Summer
-- Fares Start from $99* One Way -- SALT LAKE CITY, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Breeze Airways, the premium leisure carrier providing affordable, direct flights from underserved markets,...
-
SAN FRANCISCO and SYDNEY, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Fundbox, the leading provider of embedded capital infrastructure for small businesses, today announced its expansion into Australia,...
-
First Patient Dosed with Intranasal Foralumab in Randomized, Placebo-Controlled Phase 2 TrialBuilds on Recent Evidence of Persistent Neuroinflammation in Alzheimer’s Patients Treated with Anti-Amyloid...